pharmaphorum18 小时
Solid Bio hit as FDA slaps clinical hold on DMD gene therapy
The FDA has placed another clinical hold on a gene therapy for Duchenne muscular dystrophy developed by Solid Biosciences, pulverising its share price. The halt of the IGNITE DMD trial was ...
pharmaphorum18 小时
Sarepta files Duchenne muscular dystrophy gene therapy with FDA
Sarepta Therapeutics has followed through on its promise to file for accelerated approval of its gene therapy SRP-9001 for Duchenne muscular ... from Pfizer and Solid Biosciences – codes ...